{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009033","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.132681+00:00","generated_at":"2026-06-05T02:31:17.758402+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bone Biologics closes $2.0M public offering of shares and warrants; net proceeds ~$1.5M","bullets":["Priced 119,000 shares and 662,251 pre-funded warrants, each with warrants to buy one share at $2.43.","Combined offering price $2.56 per share and warrant; net proceeds ~$1.5M after fees.","Warrants exercisable immediately, expire in 5 years; exercise price $2.43.","Proceeds to fund clinical trials, patent portfolio, and working capital.","After closing, shares outstanding increased to 879,176."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009033","json":"https://secwatch.observer/filing/0001493152-24-009033.json","markdown":"https://secwatch.observer/filing/0001493152-24-009033.md","text":"https://secwatch.observer/filing/0001493152-24-009033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/0001493152-24-009033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:31:17.758402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3cbf5d470df44508cab845acd3d3ac545e0407a","claim":"Bone Biologics Corp entered into Securities Purchase Agreement with certain institutional investors valued at Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran (effective 2024-03-04).","evidence_excerpt":"On March 4, 2024, Bone Biologics Corporation (the “Company”) priced a public offering (the “Offering”) of (i) 119,000 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), together with warrants (the “Warrants”) to purchase 119,000 shares of Common Stock at a combined public offering price of $2.56 per Share and accompanying Warrant and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 662,251 shares of Common Stock, together with Warrants to purchase 662,251 shares of Common Stock at a combined public offering price of $2.559 per Pre-Funded Warrant and accompanying Warrant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/0001493152-24-009033-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran"},{"label":"Effective","value":"2024-03-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}